Table 2.

Categorical variables age, gender, number of patients hospitalized, and change in antibiotics of 188 pediatric patients with MS and MR M. pneumoniae pneumonia according to treatment group

Variable	MS patient treatment group:		MR patient treatment group:
	AZMa	CLRb	AZM	CLR	TFXc	MINd
No. of patients	16	22	27	23	62	38
Mean age (range), yr	8.6 (1–13)	8.0 (2–15)	8.4 (1–14)	8.0 (3–15)	6.5 (0–15)	9.8 (1–15)
No. (%) of patients:
<1 yr old	1 (6.3)	1 (4.6)	1 (3.7)	0	5 (8.1)	1 (2.6)
2–5 yr old	5 (31.3)	6 (27.3)	5 (18.5)	8 (34.8)	23 (37.1)	6 (15.8)
6–7 yr old	4 (25)	3 (13.6)	7 (25.9)	3 (13.0)	13 (21.0)	0
8 yr old	6 (37.5)	12 (54.5)	14 (51.9)	12 (52.2)	21 (33.9)	31 (81.6)
No. of males/females	8/8	14/8	13/14	14/9	35/27	22/16
No. (%) hospitalized	0	0	1 (3.7)	3 (13.0)	5 (8.1)	6 (15.8)
No. (%) with antibiotic change at second visit	0	0	10 (37.0)e	13 (56.5)f	0	0

^aAZM, azithromycin.

^bCLR, clarithromycin.

^cTFX, tosufloxacin.

^dMIN, minocycline.

^eAntibiotic changed to TFX for five patients and to MIN for five patients.

^fAntibiotic changed to TFX for six patients and to MIN for seven patients.